Skip to main content
Top

Journal of Cancer Education

Issue Special Issue 2/2009

Content (25 Articles)

Editorial

Thank you to the Intercultural Cancer Council!

Joseph O’Donnell

Editorial

A bridge to somewhere

Armin D. Weinberg

Effective Leadership

Leadership in public health

Howard K. Koh

Using a biopsychosocial approach to address health disparities—One person’s vision

Denae W. King, Thelma C. Hurd, Richard A. Hajek, Lovell A. Jones

EDICT as A Model for Action

The case for eliminating disparities in clinical trials

Daniel Goldberg

Voices of the Community

Breast health issues of undocumented women in California and Texas

Evaon Wong-Kim, Janice A. Chilton, Siang Sin Goh, Venus Gines

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine